Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company VaxInnate Corp.
DescriptionRecombinant influenza M2e vaccine fused to the TLR5 ligand flagellin as adjuvant
Molecular Target Matrix protein 2 extracellular domain (M2e) ; Toll-like receptor 5 (TLR5)
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase I/II
Standard IndicationInfluenza virus
Indication DetailsPrevent influenza virus infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today